Related Experiment Videos
Selective damage of hippocampal neurons in murine cerebral malaria prevented by pentoxifylline
G Stoltenburg-Didinger1, S Neifer, U Bienzle
1Institute of Neuropathology, Klinikum Steglitz, Free University, Berlin, Germany.
Abstract:
The effect of pentoxifylline, a phosphodiesterase inhibitor, was investigated on the development of cerebral malaria in Plasmodium berghei K 173 infected C57/B16 mice. No significant differences occurred in the course of parasitemia and survival time after infection between control mice and pentoxifylline treated mice. Moreover, no differences were observed between the groups with respect to the occurrence of cerebral malaria. The only striking difference was that pentoxifylline treatment selectively prevented neuronal cell damage in the sector CA1 of the hippocampus. These findings are in contrast to previous studies, where pentoxifylline prevented cerebral malaria in P. berghei ANKA infected CBA/Ca mice, another widely used model of cerebral malaria. Obvious differences exist between these models.
Insights
Pentoxifylline did not prevent cerebral malaria in Plasmodium berghei K 173 infected mice. However, this phosphodiesterase inhibitor selectively protected hippocampal neurons from damage.
Area of Science:
- Neuroscience
- Immunology
- Parasitology
Background:
- Cerebral malaria is a severe complication of Plasmodium falciparum infection.
- Pentoxifylline, a phosphodiesterase inhibitor, has shown neuroprotective effects in some models.
- Previous studies suggested pentoxifylline could prevent cerebral malaria.
Purpose of the Study:
- To investigate the effect of pentoxifylline on cerebral malaria development in a Plasmodium berghei K 173 mouse model.
- To assess the impact of pentoxifylline on parasitemia, survival, cerebral malaria occurrence, and neuronal damage.
Main Methods:
- C57/B16 mice were infected with Plasmodium berghei K 173.
- Mice were treated with pentoxifylline or a placebo.
- Parasitemia, survival, cerebral malaria, and hippocampal neuronal damage were evaluated.
Main Results:
- Pentoxifylline treatment did not alter parasitemia or survival rates.
- No significant difference in cerebral malaria occurrence was observed between groups.
- Pentoxifylline selectively prevented neuronal cell damage in the hippocampus (sector CA1).
Conclusions:
- Pentoxifylline does not prevent cerebral malaria in the P. berghei K 173 model.
- The drug demonstrates selective neuroprotection in the hippocampus despite lack of efficacy against cerebral malaria.
- Differences in experimental models may explain conflicting results with previous studies.